tbuckley/cabot-search huggingface dataset:
Investigatory study of biomarkers for gastric cancer based on a cDNA bank.
Authors: Takashi Oshima, Toshio Imada, Chikara Kunisaki, Takaki Yoshikawa, Yasushi Rino, Munetaka Masuda
Journal: Journal of Clinical Oncology (2012)

4070 Background: We have constructed a cDNA bank using mRNA extracted from frozen specimens of gastric cancer tissue and adjacent normal gastric mucosa and studied biomarkers for the individualized therapy of gastric cancer and the identification of new treatment targets. We report currently available results. Methods: We studied 227 patients in whom at least 5 years had elapsed since surgery for gastric cancer. The disease stage was IB in 29 patients, II in 66, III in 103, and IV in 29. Among the 139 patients who postoperatively received fluoropyrimidine anticancer agents, 82 with stage II or III disease were given adjuvant chemotherapy with S-1. A total 116 genes were selected as candidate biomarkers on the basis of the results of comprehensive DNA microarray analysis, extraction from a serial analysis of gene expression (SAGE) database, and other studies. The relative expression levels of these 116 genes in gastric cancer tissue and adjacent normal mucosa were measured in each case by a quantitative polymerase chain reaction assay using the cDNA databank described above, and the relations between clinical histopathological factors and treatment outcomes were examined. Results: In patients who underwent gastrectomy, high expression levels of the secreted protein acidic and rich in cysteine (SPARC), sulfatase 1 (SULF1), and inhibin, beta A (INHBA) genes were significantly associated with poor outcomes. In patients with stage II or III disease who received adjuvant chemotherapy with S-1, high expression levels of the insulin-like growth factor receptor 1 (IGF-1R), KIAA1199, thymidylate synthase (TS), and regenerating IV (Reg IV) genes were significantly associated with poor survival. Conclusions: Investigatory studies using a cDNA bank of biomarkers for gastric cancer suggested that expression levels of the SPARC, SULFI, and INHBA genes are useful prognostic factors in patients who undergo gastrectomy for gastric cancer. Expression levels of the IGF-1R, KIAA1199, TS, Reg IV, and INHBA genes may be useful biomarkers in patients who receive adjuvant chemotherapy with S-1.
MLN0128, a Second-Generation mTOR Kinase Inhibitor, Disrupts Survival Signaling and Triggers Apoptosis in AML
Authors: Zhihong Zeng, Rui-Yu Wang, Yuexi Shi, Yihua Qiu, Duncan H Mak, Kevin Coombes, Suk Young Yoo, Katti Jessen, Yi Liu, Christian Rommel, Hagop M. Kantarjian, Steven M. Kornblau, David Fruman, Michael Andreeff, Marina Konopleva
Journal: Blood (2014)
Rituximab Resistance Is Associated with Global Downregulation of CD20 and CD54 In B-Cell Lymphoma Cells: Implication of CD20 Signaling on CD54
Authors: Ping-Chiao Tsai, Peter Dvorak, Naveen Bangia, Scott Olejniczak, Myron S. Czuczman, Francisco J. Hernandez-Ilizaliturri
Journal: Blood (2010)
Correlation of Expression of CD25 in Hematopoietic Stem/Progenitor Cell Fraction of Bone Marrow Cells with Response to Tyrosine Kinase Inhibitors in Chronic Myelogenous Leukemia Patients
Authors: Daiki Karigane, Hidenori Kasahara, Masatoshi Sakurai, Eri Matsuki, Keiichi Tozawa, Yuya Koda, Takaaki Toyama, Taku Kikuchi, Jun Kato, Takayuki Shimizu, Takehiko Mori, Yoko Yatabe, Tomoko Arai, Takayuki Mitsuhashi, Mitsuru Murata, Hiroshi Kobayashi, Keiyo Takubo, Shinichiro Okamoto
Journal: Blood (2016)
Nanotherapeutics for neurosurgically-applied drug delivery
Authors: Catherine Vasey, Vincenzo Taresco, Stuart Smith, Cameron Alexander, Ruman Rahman
Journal: Neuro-Oncology (2019)

Abstract Despite multimodal treatment, the median survival of Glioblastoma multiforme (GBM) remains less than 15 months, in considerable part due to diffusely infiltrative disease. Better treatment methods are necessary to eradicate residual tumour burden remaining beyond the resection cavity boundary. Based on an increasing understanding of GBM intra-tumour heterogeneity, the capability to deliver multiple therapeutic moieties from single formulations is clinically-relevant. It is hypothesised that incorporating drug-loaded polymer pro-drugs, which are capable of transcytotic ‘hopping’, into a biodegradable microparticulate paste will lead to efficacious local delivery. Here we report the formulation of numerous self-assembling cytocompatible nanoparticles, based on different linear and branched polymeric architectures. The polymers were synthesised by ring opening polymerisation with organic catalysts, leading to controlled reaction kinetics and greater potential biomedical applicability. We demonstrated that copolymerisation of a monomer with functional capability enabled the successful conjugation of doxorubicin to the polymer chain. We hypothesised that polymers with a greater degree of branching over traditional linear structures would lead to greater drug loading, and successfully tested this hypothesis through the encapsulation of olaparib. We will discuss strategies to incorporate: i) pH-sensitive linkers to the polymeric backbone, which would allow controlled drug release in acidic microenvironments; ii) multiple combined chemotherapeutics, including doxorubicin and olaparib. Future work will assess the efficacy of the polymer pro-drugs against primary GBM lines derived from the invasive margin and safety/efficacy using orthotopic syngeneic allografts. This is the first study incorporating polymer pro-drugs of this type into an existing localised micro-scale delivery system for GBM therapies.
Two Novel Mutations in Ribosomal Proteins in the Czech National Diamond-Blackfan Anemia Registry
Authors: Zuzana Maceckova, Pavla Koralkova, Jana Volejnikova, Petr Vojta, Alexandra Jungova, Zuzana Saxova, Renata Mojzikova, Marie Jarosova, Ivana Hadacova, Marian Hajduch, Monika Horvathova, Dagmar Pospisilova
Journal: Blood (2016)
Post Induction Minimal Residual Disease Levels Identifies a Group of High Risk Relapsed Childhood Acute Lymphoblastic Leukemia (rALL) with a Favorable Outcome Independent of Induction Therapy
Authors: Catriona Anne Parker, Marie Reeves, Sharon Love, Jeremy Hancock, Peter M Hoogerbrugge, Rosemary Sutton, Tom Revesz, Vaskar Saha
Journal: Blood (2015)
Multicentric Analyses of the CD148, CD180, and CD200 Combination for the Diagnosis of Mature B-Cell Neoplasm Using Flow Cytometry
Authors: Laurent Miguet, Luc Fornecker, Marie Wyrwas, Sarah Cianferani, Raoul Herbrecht, Jean-Francois Leseve, Veronique Latger-Cannard, Caroline Mayeur-Rousse, Laurent Mauvieux
Journal: Blood (2015)
Monitoring of Minimal Residual Disease in NPM1 Mutated Acute Myeloid Leukemia (AML): Results of the AML Study Group (AMLSG)
Authors: Jan Krönke, Richard Schlenk, Kai-Ole Jensen, Karina Eiwen, Marianne Habdank, Daniela Späth, Jürgen Krauter, Arnold Ganser, Hartmut Döhner, Konstanze Döhner
Journal: Blood (2008)
Monocytic Leukemia Associated Antigen-34 Mediates Extramedullary Infiltrationand and Tumor Invasion in Acute Myeloid Leukemia
Authors: Yan Peng, Hongli Chen, Yun Yang, Ju Bai, Xiaman Wang, Ying Shen, Yuandong Feng, Jing Liu, Yue Peng, Aili He
Journal: Blood (2016)
Activation Of Natural Killer Cells By Soypeptide Lunasin and Cytokine: Implication In Cancer Immunotherapy For Lymphoma
Authors: Chun-Yu Tung, Sharifah Kyazike, David Lewis, Ling Han, Alexander Kolb, David Pelloso, Anthony Sinn, Karen E. Pollok, Shivani Srivastava, Michael J. Robertson, Hua-Chen Chang
Journal: Blood (2013)
Chronic Lymphocytic Leukemia Apoptotic Cell Death Induced by Glucocorticoids Is Mediated by BIM and GILZ and Can Be Predicted by FKBP5 Basal Expression Levels.
Authors: Maria Joao Baptista, Ana Muntañola, Carles Codony, Eva Calpe, Eva Fernandez, Marta Crespo, Pau Abrisqueta, Eva Gine, Susana G Kalko, Pedro Jares, Emili Montserrat, Francesc Bosch
Journal: Blood (2009)
Dapagliflozin reduced cardiorenal outcomes but not MACE in T2 diabetes with or at risk for atherosclerotic CVD
Authors: Louise Moist
Journal: Annals of Internal Medicine (2019)

Source Citation Wiviott SD, Raz I, Bonaca MP. Dapagliflozin and cardiovascular outcomes in type 2 diabetes. N Engl J Med. 2019;380:347-57. 30415602 Mosenzon O, Wiviott SD, Cahn A, et al. Effects of...
Prolonged Survival without Complete Remission (CR) In AML Patients (Pts) Treated with Azacitidine (AZA)
Authors: Raphael Itzykson, Sylvain Thepot, Odile Beyne-Rauzy, Bruno Quesnel, Shanti Ame, Pascal Turlure, Stephanie Harel, Anne Marfaing-Koka, Youcef Chelgoum, Aspasia Stamatoullas, Madalina Uzunov, Norbert Ifrah, Herve Dombret, Lionel Ades, CL Beach, Arlene S. Swern, Claude Gardin, Pierre Fenaux
Journal: Blood (2010)
Incidence and Risk Factors for Lower Alimentary Tract Mucositis (neutropenic enterocolitis) Following 1528 Courses of Chemotherapy in a Homogenous Population of Myeloma Patients: Clinical and Research Implications.
Authors: Somashekar G Krishna, Zhao Weizhi, Kavya Krishna, Monica Grazziutti, Bart Barlogie, Elias Anaissie
Journal: Blood (2009)
Synergistic Interaction of the Histone Deacetylase Inhibitor SAHA with the Proteasome Inhibitor Bortezomib in Mantle Cell Lymphoma.
Authors: Ulrike Heider, Martin Kaiser, Ivana Zavrski, Jan Sterz, Christian Jakob, Claudia Fleissner, Monica Hecht, Lorenz Kleeberg, Christian Braun, Kurt Possinger, Orhan Sezer
Journal: Blood (2006)
Effects of Ponatinib and Other Novel TKI On Growth, Survival, and Function of Neoplastic Eosinophils Carrying FIP1L1/Pdgfra
Authors: Irina Sadovnik, Peter Valent, Els Lierman, Harald Herrmann, Barbara Peter, Verena Suppan, Gabriele Stefanzl, Winfried F Pickl, Jan Cools, Peter Vandenberghe
Journal: Blood (2012)
Human CD8+/TCR−/CD56dim/- Facilitating Cells Facilitate Homing and Engraftment of Human HSC in Vivo
Authors: Yiming Huang, Mary J Elliott, Thomas Miller, Deborah R Corbin, Larry D. Bozulic, Hong Xu, Yujie Wen, Maryam Jazayeri, Suzanne T. Ildstad
Journal: Blood (2012)
Anemia in Hodgkin Lymphoma: The Role of Interleukin-6 and Hepcidin.
Authors: Stefan Hohaus, Barbara Vannata, Manuela Giachelia, Maria Ilaria Roselli, Giuseppina Massini, Annarosa Cuccaro, Maria Chiara Tisi, Marianna Criscuolo, Francesco D'Alo, Harold Tjalsma, Dorine W. Swinkels, Maria Teresa Voso, Giuseppe Leone
Journal: Blood (2009)
Poor Prognostic Effect of CD5 Positivity for Patients with Diffuse Large B-Cell Lymphoma: Results from a Retrospective Single Institution Analysis
Authors: Lapo Alinari, Alejandro Gru, Carl Quinion, Ying Huang, Jeffrey A. Jones, Steven M. Devine, Kami J. Maddocks, Beth Christian, Robert A. Baiocchi, Kristie A. Blum
Journal: Blood (2014)
SGN-CD33A Plus Hypomethylating Agents: A Novel, Well-Tolerated Regimen with High Remission Rate in Frontline Unfit AML
Authors: Amir T. Fathi, Harry P Erba, Jeffrey E Lancet, Eytan M Stein, Roland B. Walter, Daniel J. DeAngelo, Stefan Faderl, Anand P Jillella, Farhad Ravandi, Anjali S. Advani, Dale Bixby, Tibor J. Kovacsovics, Megan M. O'Meara, Dana A. Kennedy, Anthony S. Stein
Journal: Blood (2015)
Proteasome Inhibitor, Bortezomib Induces Mesenchymal Stem Cells toward Osteoblast Differentiation through Wnt-Independent Activation of Beta-catenin/TCF Signaling
Authors: Ya-Wei Qiang, Bo Hu, Yu Chen, Ying Zhong, Bingyin Shi, Bart Barlogie, John D Shaughnessy
Journal: Blood (2008)
Contrasting multidisciplinary clinic follow up for patients with high and low grade glioma.
Authors: Giles Critchley, Sorin Bucur, Gill Walsh, Ruth Smith, Antonia Creak, Juliet Brock
Journal: Neuro-Oncology (2019)

Abstract Patients with high grade glioma (HGG) and low grade glioma (LGG) may enter a period of stability in their disease when surveillance is required; during this time they often require different forms of support. We describe two different multidisciplinary clinics approaches to patients with gliomas, both of which are linked to the relevant multidisciplinary meetings (MDMs). Since 1987 the ‘joint glioma clinic’ (HGG clinic) has been run with a neurosurgeon, neurooncologist and clinical nurse specialist seeing patients and their carers in one room. Patients under surveillance undergo MRI scans and if there is evidence of recurrence then an immediate discussion can be held with the patient regarding options for further management. Since 2011 the Low grade glioma clinic (LGG clinic) has run with a multi room model. There are two neurosurgeons, a neurooncologist, a neuroradiologist, a neuropsychologist, a neurologist and a clinical nurse specialist present who discuss patients in a MDM. Subsequently a patient may then see one or more of the team in sequence in different rooms as needed. This allows issues such as epilepsy, neuropsychology, treatment options and surveillance intervals to be discussed with patients at one visit. There is a cohort of 106 patients under surveillance in the HGG joint glioma clinic and 270 patients in the LGG clinic. We believe a single visit can minimize the impact of the disease and provide different forms of support a needed. Both models allow rapid decision making when the period of surveillance ends due to transformation or recurrence.
Cyclophosphamide, Gemcitabine, Vinorelbine and Prednisone (CGEV) As Salvage Therapy for Relapsed or Refractory Hodgkin´s Lymphoma before Hematopoietic Stem Cell Transplantation: A Single Center Experience
Authors: Daniela Cárdenas-Araujo, Xitlaly Judith Gonzalez-Leal, David Gomez-Almaguer
Journal: Blood (2015)
High-Definition IVUS Versus OCT to Assess Coronary Artery Disease and Results of Stent Implantation
Authors: Marcos Garcia-Guimaraes, Paula Antuña, Francisco De la Cuerda, Ramón Maruri-Sanchez, Javier Cuesta, Teresa Bastante, Fernando Rivero, Fernando Alfonso
Journal: JACC. Cardiovascular imaging (2019)
The Identification and Use of a Three Fungus-Antigen Combination to Generate T-Cell Products with Activity Against Pathogenic Filamentous Fungi and Yeasts for Clinical Cell Therapy
Authors: Shiva Deo, Balaji Virassamy, Catriona Halliday, Leighton Edward Clancy, Wieland Meyer, Sharon Chen, Tania Sorrell, David Gottlieb
Journal: Blood (2014)
Identification of Inducers of Megakaryocyte Polyploidization and Their Use as Targeted Differentiation Therapy for Acute Megakaryocytic Leukemia.
Authors: Qiang Wen, Zan Huang, Sara Small, Niket Bubna, Frank An, Meghan Bliss-Moreau, Lynn Verplank, Tim Lewis, Monica Schenone, Nicola Tolliday, Chris Moore, Ann Carpenter, Thomas Mercher, Ross L. Levine, Shai Izraeli, Andrew Stern, Robert Gould, James E. Bradner, John Crispino
Journal: Blood (2009)
A Phase I Study of AC220 in Combination with Cytarabine and Etoposide in Relapsed/Refractory Childhood ALL and AML: A Therapeutic Advances in Childhood Leukemia &amp; Lymphoma (TACL) Study
Authors: Todd Cooper, Richard Sposto, Jeannette Cassar, Elena Eckroth, Jemily Malvar, Paul Gaynon, Steven Dubois, Bill H Chang, Lia Gore, Keith J. August, Blythe Thomson, Guy Gammon, Daniel Magoon, Colleen E. Annesley, Patrick Brown
Journal: Blood (2012)
PD-1/PD-L1 Blocking Enhances CD33/CD3-Bispecific BiTE® Antibody (AMG 330) Mediated Lysis of Primary AML Cells
Authors: Christina Krupka, Peter Kufer, Roman Kischel, Gerhard Zugmaier, Thomas Köhnke, Felix S Lichtenegger, Frauke M Schnorfeil, Torben Altmann, Stephanie Schneider, Michael Fiegl, Karsten Spiekermann, Angus M Sinclair, Kathryn J Newhall, Stanley R Frankel, Patrick Baeuerle, Wolfgang Hiddemann, Gert Riethmüller, Marion Subklewe
Journal: Blood (2014)
A Comparison Of Acute Myelogenous Leukemia Induction Therapies: High Dose Daunorubicin Vs Idarubicin
Authors: Viet Q. Ho, Robert Cade, Gene A. Wetzstein, Van D Hoang, Alan List, Eric Padron, Hugo F Fernandez, Jeffrey E Lancet, Rami S Komrokji
Journal: Blood (2013)
Oral Administration of Carbon-14 Labeled Cyanocobalamin (14C-Cbl) Reveals Variable Degradation of Vitamin B12 in the Gastrointestinal Tract That Impacts Vitamin B12 Absorption and Status.
Authors: Ralph Green, Joshua W Miller, Kyung-Seon Lee, Syrukh Sutter, Lindsay H Allen, Bruce A Buchholz, Stephen Dueker
Journal: Blood (2009)
Risk and Response Adapted Conventional Treatment Strategy in 146 Patients with AL Amyloidosis
Authors: Arnaud Jaccard, Frank Bridoux, Estibaliz Lazaro, Olivier Tournilhac, Margareth Macro, Murielle Roussel, Bruno Moulin, Xavier Leleu, Mamoun Did, Sylvain Choquet, Pierre Morel, Bruno Royer, David Lavergne, Charlotte Rigaud, Jean Paul Fermand
Journal: Blood (2014)
Comorbidity Scoring Using the Hematopoetic Cell Transplantation Comorbidity Index (HCTCI) Is Predictive of Early Death Rate and Event Free Survival (EFS) in Patients over 60 Years of Age Receiving Induction Therapy for Acute Myeloid Leukemia (AML).
Authors: Francis Giles, Gautam Borthakur, Farhad Ravandi, Stefan Faderl, Srdan Verstovsek, Sherry Pierce, Elias Jabbour, Jorge Cortes, Hagop Kantarjian
Journal: Blood (2006)
A Fludarabine Based Conditioning Regimen Associated with A Good Survival Following HLA Identical Sibling/Family Donor Transplants in Patients with Aplastic Anemia.
Authors: Mammen Chandy, Biju George, Vikram Mathews, Shashikant Apte, Velu Nair, Uday Deotare, Rajasekhar Thiurgnanam, Anjali Jaydeep Kelkar, Samir Melinkeri, Satyaranjan Das, Ajay Sharma, Auro Viswabandhya, Alok Srivastava
Journal: Blood (2009)
At-101 Induces Apoptosis Waldenström Macroglobulinemia Cells Resistant to Bortezomib.
Authors: Kasyapa Chitta, Kiersten M. Miles, Pushpankur Ghoshal, Leighton Stein, Morton Coleman, Richard R Furman, Hofmeister Craig, Suzanne Hayman, Kelvin P. Lee, Asher Alban Chanan-Khan
Journal: Blood (2009)
A Novel Beneficial Role for Macitentan in Patients at High Thrombosis Risk: Attenuation of Platelet-Mediated Derangements of Blood Coagulation in Eisenmenger Syndrome
Authors: Barry Kevane, Seamus Allen, Kevin Walsh, Karl Egan, Patricia Maguire, Damien Kenny, Susan Crawford, Áine Lennon, Rhona Savage, Esther Doran, Elaine Neary, Fionnuala Ní Áinle
Journal: Blood (2016)
Calcitonin Gene-Related Peptide Negatively Regulates Alarmin-Driven Type 2 Innate Lymphoid Cell Responses
Authors: Antonia Wallrapp, Patrick R. Burkett, Samantha J. Riesenfeld, Se-Jin Kim, Elena Christian, Raja-Elie E. Abdulnour, Pratiksha I. Thakore, Alexandra Schnell, Conner Lambden, Rebecca H. Herbst, Pavana Khan, Kazutake Tsujikawa, Ramnik J. Xavier, Isaac M. Chiu, Bruce D. Levy, Aviv Regev, Vijay K. Kuchroo
Journal: Immunity (2019)
NDRG1 Expression Is Inhibited in AML and Its Knockdown Attenuates Neutrophil Differentiation.
Authors: Mario P. Tschan, Deborah Shan, Judith Laedrach, Marianne Eyholzer, Elisabeth Oppliger Leibundgut, Gabriela Baerlocher, Andreas Tobler, Deborah Stroka, Martin F. Fey
Journal: Blood (2008)
A retrospective study of immune-related adverse events in various solid tumors
Authors: Keitaro Shimozaki, Yasutaka Sukawa, Noriko Beppu, Isao Kurihara, Shigeaki Suzuki, Seiji Asoda, Hiroyuki Ozawa, Ryuichi Mizuno, Takeru Funakoshi, Shinnosuke Ikemura, Kai Tsugaru, Kazuhiro Togasaki, Kenta Kawasaki, Kenro Hirata, Hideyuki Hayashi, Yasuo Hamamoto, Takanori Kanai, Hiromasa Takaishi
Journal: Annals of Oncology (2019)
Acquisition Of Compound BCR-ABL1 Alleles As A Mechanism Of Resistance To Ponatinib In Chronic Myeloid Leukemia
Authors: Don L Gibbons, Sabrina Pricl, Paola Posocco, Erik Laurini, Maurizio Fermeglia, Moshe Talpaz, Jorge E. Cortes, Nicholas J. Donato, Alfonso Quintas-Cardama
Journal: Blood (2013)
Differential Patterns of Gene Expression and CD20 Localisation by the Type II Anti-CD20 Antibody Obinutuzumab (GA101) Compared with the Type I Antibody Rituximab Suggests Binding to Functionally Distinct CD20 Subpopulations on B-Cell Lymphoma Cell Lines,
Authors: Gerhard Niederfellner, Olaf Mundigl, Alexander Lifke, Andreas Franke, Ute Baer, Helmut Burtscher, Daniela Maisel, Anton Belousov, K. Michael Weidner, Pablo Umana, Christian Klein
Journal: Blood (2011)
Relationship between travel time to primary and tertiary care centres and survival in glioblastoma: the NHS Grampian experience.
Authors: Damjan Veljanoski, Raphae Barlas, Aimun Jamjoom, Phyo Myint
Journal: Neuro-Oncology (2019)

Abstract Background Studies have demonstrated a distance-decay effect, whereby patients who live further away from their healthcare facility have poorer health outcomes. The geographical catchment area served by the neurosurgical unit in Aberdeen, Grampian region, Scotland is one of the largest in the UK. We aimed to examine the relationship between travel time as a proxy of distance travelled, and survival outcome for glioblastoma. Methods We conducted a retrospective, cohort analysis of patients with glioblastoma referred for treatment from January 2009 to December 2018. Travel time was calculated from the patients’ home to their general practitioner (GP) and to the neurosurgical unit. Logistic regression models were constructed to estimate survival at three, six and 12 months, as well as treatment within 62 days of GP referral, and within 31 days of diagnosis controlling for age, sex and treatment type. Results There were 195 patients (mean age (SD) 64.4 ± 12.9 years)57.9% were men, 65.1% were treated surgically, and 48.2% were alive after one year. Longer time travelled to GP, but not to tertiary care centre, was associated with reduced odds of mortality at three months (OR 0.88 95%CI 0.79–0.98; p=0.005) and six months (OR 0.92 95%CI 0.85–0.99; p=0.01), for each incremental increase in one minute. Conclusions Patients with glioblastoma with longer travel times to their GP were more likely to be alive at three months and six months. Further work is required to identify other factors, including degrees of socio-economic deprivation and rurality, which may influence this finding.
MAF Induces Inflammatory Mediators Involved in the Pathogenesis of Primary Myelofibrosis
Authors: Samantha Ruberti, Elisa Bianchi, Tiziana Fanelli, Sebastiano Rontauroli, Valentina Pennucci, Giuditta Corbizzi Fattori, Carmela Mannarelli, Ruggiero Norfo, Chiara Rossi, Roberta Zini, Simona Salati, Zelia Prudente, Enrico Tagliafico, Paola Guglielmelli, Alessandro M. Vannucchi, Rossella Manfredini
Journal: Blood (2016)
Preliminary Safety Results from the Phase IIIb GREEN Study of Obinutuzumab (GA101) Alone or in Combination with Chemotherapy for Previously Untreated or Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)
Authors: Francesc Bosch, Thomas Illmer, Mehmet Turgut, Agostino Cortelezzi, Susan F. Lasserre, Anna Truppel-Hartmann, Veronique Leblond, Robin Foà, Stephan Stilgenbauer
Journal: Blood (2014)
Zygomycosis After Allogeneic Hematopoietic Stem Cell Transplantation: A French Multicenter Cohort Study (2003-2008)
Authors: Alienor Xhaard, Fanny Fanternier, Eric Dannaoui, Anne Bergeron-Lafaurie, Claire Lacroix, Raoul Herbrecht, Faezeh Legrand, Mohamad Mohty, Mauricette Michallet, Catherine Cordonnier-Carlet, Sandra Malak, Denis Guyotat, Louis Jean Couderc, Gerard Socie, Olivier Lortholary, Patricia Ribaud
Journal: Blood (2010)
Phase I Dose-Escalation Study of CAT-8015 (HA22), A CD22-Specific Targeted Immunotoxin, in Relapsed or Refractory Hairy Cell Leukemia.
Authors: Robert J Kreitman, Martin S. Tallman, Steven Coutre, Tadeusz Robak, Wyndham H Wilson, Maryalice Stetler-Stevenson, Pierre Noel, David J. FitzGerald, Manuela Buzoianu, Robert Lechleider, Karen Kaucic, Ira Pastan
Journal: Blood (2009)
Proof of Principle for Mutations Monitoring Using Picoliter-Droplet Digital PCR on DNA and Living Cells: Application to Myelodysplastic Syndromes
Authors: Hélène Guermouche, Philippe Nizard, Heng Lu, Charles Decraene, Juliette Nectoux, Pierre Laurent-Puig, Charlotte Proudhon, Michaela Fontenay, Valérie Taly, Olivier Kosmider
Journal: Blood (2016)
Phase II Trial of Prochymal™ (Ex-Vivo Cultured Adult Human Mesenchymal Stem Cells) and Corticosteroids as Primary Treatment for Acute Graft-Vs-Host Disease (aGVHD).
Authors: Partow Kebriaei, Luis Isola, Erkut Bahceci, H. Kent Holland, Scott Rowley, Joseph McGuirk, Marcel Devetten, Jan Jansen, Roger Herzig, Michael Schuster, Joseph Uberti
Journal: Blood (2006)
Methylenetetrahydrofolate Reductase (MTHFR) C677T Polymorphism Decreases Risk of Childhood Acute Lymphoblastic Leukemia (ALL): A Study of the Chinese and Malay Population.
Authors: Shirley Kow Yin Kham, Toon Chai Foo, Ariffin Hany, Yiong Huak Chan, Hai Peng Lin, Thuan Chong Quah, Allen Eng Juh Yeoh
Journal: Blood (2005)